Is this you? Create Your Porfile
Avatar

Michael Cain

Novo Nordisk

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Michael Cain is active.

Explore More

Publication

Featured researches published by Michael Cain.

Archive | 1997

Modified form of the R(-)-N-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride

Preben Ahrndt; Henning Petersen; Vincent H. Chang; Kimberly Ann Allen; Michael Cain

Organic Process Research & Development | 2004

A scaleable synthesis of fiduxosin

Anthony R. Haight; Anne E. Bailey; William S. Baker; Michael Cain; Richard R. Copp; John Demattei; Kelley L. Ford; Rodger F. Henry; Margaret Chi-Ping Hsu; Robert F. Keyes; Steven A. King; Maureen A. McLaughlin; Laura Melcher; William R. Nadler; Patricia A. Oliver; Shyamal I. Parekh; Hemant H. Patel; Louis S. Seif; Mike A. Staeger; Gregory S. Wayne; Steven J. Wittenberger; Weijiang Zhang

Archive | 1992

Crystalline Tiagabine monohydrate, its preparation and use

Henning Petersen; Peter Kresten Nielsen; Michael Cain; Subhash R. Patel

Organic Process Research & Development | 1998

A Scalable Process for the Novel Antidepressant ABT-200

Mahendra N. Deshpande; Michael Cain; Subhash R. Patel; Pulla R. Singam; David Brown; Ashok K. Gupta; Jufang H. Barkalow; Gary Callen; Ketan Patel; Roger Koops; Mukund S. Chorghade; Howard Foote; Richard J. Pariza

Archive | 1992

Crystalline tiagabine hydrochloride monohydrate, its preparation and use

Henning Petersen; Peter Kresten Nielsen; Michael Cain; R Subhash Patel

Archive | 2000

Procede de reduction d'acide (2r)-4-oxoazetidinone-2-carboxylique

James E. Resek; Shyamal I. Parekh; Pulla R. Singam; Hermant H. Patel; Michael Cain; Bikshandarkoil A. Narayanan

Archive | 2000

Process for reduction of (2R)-4-oxoazetidinone-2-carboxylic acid

James E. Resek; Shyamal I. Parekh; Pulla R. Singam; Hermant H. Patel; Michael Cain; Bikshandarkoil A. Narayanan

Archive | 1993

Förfarande för framställning av terapeutiskt användbara kristallint Tiagabine-hydrokloridmonohydrat

Henning Petersen; Peter Kresten Nielsen; Michael Cain; R Subhash Patel

Archive | 1993

Tiagabine crystal-hydrokloridmonohydrat, och dess dess framstaellning anvaendning

Henning Petersen; Peter Kresten Nielsen; Michael Cain; R Subhash Patel

Archive | 1993

Process for the preparation of therapeutically useful crystalline Tiagabine hydrochloride monohydrate

Henning Petersen; Peter Kresten Nielsen; Michael Cain; R Subhash Patel

Explore More

Collaboration

Dive into the Michael Cain's collaboration.

Top Co-Authors
Avatar

Henning Petersen

Novo Nordisk

View shared research outputs
Top Co-Authors
Avatar

Peter Kresten Nielsen

Novo Nordisk

View shared research outputs
Top Co-Authors
Avatar

R Subhash Patel

Novo Nordisk

View shared research outputs
Top Co-Authors
Avatar

Subhash R. Patel

Novo Nordisk

View shared research outputs
Top Co-Authors
Avatar

Shyamal I. Parekh

Texas A

View shared research outputs
Top Co-Authors
Avatar

John Demattei

Icos

View shared research outputs
Top Co-Authors
Avatar

Louis S. Seif

Seton Hall University

View shared research outputs
Top Co-Authors
Avatar

Maureen A. McLaughlin

Colorado State University

View shared research outputs
Top Co-Authors
Avatar

Mukund S. Chorghade

Millennium Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Patricia A. Oliver

Vertex Pharmaceuticals

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge